Kassira Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$484K Hold
8,398
0.39% 47
2026
Q1
$509K Buy
8,398
+2
+0% +$117 0.47% 43
2025
Q4
$453K Sell
8,396
-266
-3% -$12.8K 0.43% 39
2025
Q3
$391K Buy
+8,662
New +$405K 0.38% 44

Other funds holding BMY

Kassira Wealth Management's BMY Position: Q2 2026 in Review

Kassira Wealth Management held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 8,398 shares worth $484K. The position accounts for 0.39% of the portfolio, ranked #47.

Kassira Wealth Management first reported a position in BMY in Q3 2025 and has held it in 4 quarters since. The position peaked at $509K in Q1 2026. 2,511 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Kassira Wealth Management held 8,398 shares of Bristol-Myers Squibb worth $484K as of Q2 2026.
  • Kassira Wealth Management left its Bristol-Myers Squibb share count unchanged in Q2 2026.
  • Bristol-Myers Squibb made up 0.39% of Kassira Wealth Management's portfolio in Q2 2026, its #47 holding.
  • Kassira Wealth Management first reported a position in Bristol-Myers Squibb in Q3 2025 and has held it in 4 quarters since.
  • Kassira Wealth Management's Bristol-Myers Squibb position peaked at $509K in Q1 2026.
  • 2,511 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Kassira Wealth Management's 13F filing for Q2 2026, filed 7 Aug 2026.